Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Cloperan 10 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, flat, scored tablets with Remedica’s logo on one side. The tablet can be divided into two equal doses. |
Each tablet contains metoclopramide hydrochloride monohydrate equivalent to 10 mg metoclopramide hydrochloride.
Excipient(s) with known effect:
This product contains 65,0 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Metoclopramide |
The action of metoclopramide is closely associated with parasympathetic nervous control of the upper gastro-intestinal tract where it has the effect of encouraging normal peristaltic action. This provides for a fundamental approach to the control of those conditions where disturbed gastrointestinal motility is a common underlying factor. |
| List of Excipients |
|---|
|
Cellulose, microcrystalline |
PVC/Aluminium blisters. Pack sizes of 30, 100 and 1000 tablets.
PP containers with PE closure. Pack sizes of 500 and 1000 tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
8527
Date of first authorization: 26 October 1982
Date of latest renewal: 20 June 2008
| Drug | Countries | |
|---|---|---|
| CLOPERAN | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
